Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Biomaterials. 2015 Dec 2;80:11–19. doi: 10.1016/j.biomaterials.2015.11.065

Fig 4. Syngeneic islet function on TGF-β1 scaffolds.

Fig 4

(A) Blood glucose versus days post transplant for diabetic mice receiving syngeneic islet transplants on TGF-β1 scaffolds. Fat pads containing islets were removed at day 80. Dotted line indicates a blood glucose level of 250 mg/dL, and two consecutive readings above 250 would indicate graft failure. Data is from 8 scaffolds from 8 mice per condition receiving one scaffold implant into the right epididymal fat pad. * indicates P < 0.05 versus 0 μg on same day. Statistics determined by a two-way ANOVA with Bonferroni’s multiple comparisons test. (B) Blood glucose versus time following an intraperitoneal dextrose injection. Glucose tolerance test was performed on day 70.